Guido Wollmann

1.5k total citations
38 papers, 1.1k citations indexed

About

Guido Wollmann is a scholar working on Genetics, Oncology and Immunology. According to data from OpenAlex, Guido Wollmann has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Genetics, 12 papers in Oncology and 12 papers in Immunology. Recurrent topics in Guido Wollmann's work include Virus-based gene therapy research (27 papers), CAR-T cell therapy research (9 papers) and Immunotherapy and Immune Responses (8 papers). Guido Wollmann is often cited by papers focused on Virus-based gene therapy research (27 papers), CAR-T cell therapy research (9 papers) and Immunotherapy and Immune Responses (8 papers). Guido Wollmann collaborates with scholars based in Austria, United States and Germany. Guido Wollmann's co-authors include Anthony N. van den Pol, Koray Özduman, Peter Tattersall, Dorotheé von Laer, Janine Kimpel, John K. Rose, Joseph M. Piepmeier, Michael D. Robek, Claudio Acuña-Goycolea and John N. Davis and has published in prestigious journals such as Nature Communications, Journal of Neuroscience and Neurology.

In The Last Decade

Guido Wollmann

38 papers receiving 1.1k citations

Peers

Guido Wollmann
Eric Hastie United States
Carl Hay United States
R. S. Coffin United Kingdom
Maria P. Limberis United States
Kye Chesnut United States
Jenny McIntosh United Kingdom
Kenneth H. Warrington United States
Mariana Puntel United States
Eric Hastie United States
Guido Wollmann
Citations per year, relative to Guido Wollmann Guido Wollmann (= 1×) peers Eric Hastie

Countries citing papers authored by Guido Wollmann

Since Specialization
Citations

This map shows the geographic impact of Guido Wollmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Wollmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Wollmann more than expected).

Fields of papers citing papers by Guido Wollmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Wollmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Wollmann. The network helps show where Guido Wollmann may publish in the future.

Co-authorship network of co-authors of Guido Wollmann

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Wollmann. A scholar is included among the top collaborators of Guido Wollmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Wollmann. Guido Wollmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Reschke, Markus, Frederik H. Igney, Peter Maier, et al.. (2022). Evaluating Antibody Pharmacokinetics as Prerequisite for Determining True Efficacy as Shown by Dual Targeting of PD-1 and CD96. Biomedicines. 10(9). 2146–2146. 2 indexed citations
3.
Park, John, et al.. (2021). Combining Oncolytic Viruses and Small Molecule Therapeutics: Mutual Benefits. Cancers. 13(14). 3386–3386. 17 indexed citations
4.
Heilmann, Emmanuel, Janine Kimpel, Benedikt Hofer, et al.. (2021). Chemogenetic ON and OFF switches for RNA virus replication. Nature Communications. 12(1). 1362–1362. 7 indexed citations
5.
Belnoue, Elodie, Matteo A. C. Rossi, Tamara Hofer, et al.. (2021). A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity. Nature Communications. 12(1). 5195–5195. 41 indexed citations
6.
7.
Gesundheit, Benjamin, et al.. (2020). Effective Treatment of Glioblastoma Multiforme With Oncolytic Virotherapy: A Case-Series. Frontiers in Oncology. 10. 702–702. 29 indexed citations
8.
Erlmann, Patrik, et al.. (2019). In Vivo Bioimaging for Monitoring Intratumoral Virus Activity. Methods in molecular biology. 2058. 237–248. 3 indexed citations
9.
Kimpel, Janine, Fabian Heinemann, Birgit Stierstorfer, et al.. (2019). The lytic activity of VSV-GP treatment dominates the therapeutic effects in a syngeneic model of lung cancer. British Journal of Cancer. 121(8). 647–658. 32 indexed citations
10.
Mueller, Philipp, et al.. (2019). Analysis of Immunological Treatment Effects of Virotherapy in Tumor Tissue. Methods in molecular biology. 2058. 155–177. 1 indexed citations
11.
Wollmann, Guido, Lisa Egerer, Alexander Muik, et al.. (2016). Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy. Molecular Therapy — Oncolytics. 3. 16021–16021. 72 indexed citations
12.
Wollmann, Guido, Eugene Drokhlyansky, John N. Davis, Connie Cepko, & Anthony N. van den Pol. (2015). Lassa-Vesicular Stomatitis Chimeric Virus Safely Destroys Brain Tumors. Journal of Virology. 89(13). 6711–6724. 31 indexed citations
13.
Wollmann, Guido, Justin C. Paglino, Patrick R. Maloney, Sebastian A. Ahmadi, & Anthony N. van den Pol. (2014). Attenuation of vesicular stomatitis virus infection of brain using antiviral drugs and an adeno-associated virus-interferon vector. Virology. 475. 1–14. 15 indexed citations
14.
Özduman, Koray, Guido Wollmann, Joseph M. Piepmeier, & Anthony N. van den Pol. (2008). Systemic Vesicular Stomatitis Virus Selectively Destroys Multifocal Glioma and Metastatic Carcinoma in Brain. Journal of Neuroscience. 28(8). 1882–1893. 74 indexed citations
15.
Pol, Anthony N. van den, Michael D. Robek, P K Ghosh, et al.. (2006). Cytomegalovirus InducesInterferon-Stimulated Gene Expression and Is Attenuated by Interferon in the DevelopingBrain. Journal of Virology. 81(1). 332–348. 31 indexed citations
16.
Wollmann, Guido, Peter Tattersall, & Anthony N. van den Pol. (2005). Targeting Human Glioblastoma Cells: Comparison of Nine Viruses with Oncolytic Potential. Journal of Virology. 79(10). 6005–6022. 101 indexed citations
17.
Wollmann, Guido, Steffen Lenzner, Wolfgang Berger, et al.. (2005). Voltage-dependent ion channels in the mouse RPE: Comparison with Norrie disease mice. Vision Research. 46(5). 688–698. 21 indexed citations
18.
Wollmann, Guido, Claudio Acuña-Goycolea, & Anthony N. van den Pol. (2005). Direct Excitation of Hypocretin/Orexin Cells by Extracellular ATP at P2X Receptors. Journal of Neurophysiology. 94(3). 2195–2206. 55 indexed citations
19.
Ortego, Javier, Guido Wollmann, & Miguel Coca‐Prados. (2002). Differential regulation of gene expression of neurotensin and prohormone convertases PC1 and PC2 in the bovine ocular ciliary epithelium: possible implications on neurotensin processing. Neuroscience Letters. 333(1). 49–53. 9 indexed citations
20.
Ghosh, Sikha, et al.. (2001). Molecular Evidence That Human Ocular Ciliary Epithelium Expresses Components Involved in Phototransduction. Biochemical and Biophysical Research Communications. 284(2). 317–325. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026